Gene therapy in the retinal degeneration slow model of retinitis pigmentosa

Advances in Experimental Medicine and Biology

Volumn 664, Issue , 2010, Pages 611-619

  Cai, Xue ^b   Conley, Shannon M ^b   Naash, Muna I ^a  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

MEMBRANE PROTEIN; RETINA DEGENERATION SLOW PROTEIN; UNCLASSIFIED DRUG;

CELL RENEWAL; CONFERENCE PAPER; DISEASE MODEL; GENE EXPRESSION; GENE FUNCTION; GENE MUTATION; GENE THERAPY; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PHOTORECEPTOR OUTER SEGMENT; PRIORITY JOURNAL; PROTEIN FUNCTION; RDS GENE; RETINA CONE; RETINA DEVELOPMENT; RETINA ROD; RETINITIS PIGMENTOSA; VIRAL GENE DELIVERY SYSTEM;

ANIMALS; DISEASE MODELS, ANIMAL; GENE THERAPY; HUMANS; INTERMEDIATE FILAMENT PROTEINS; MEMBRANE GLYCOPROTEINS; MUTATION; NERVE TISSUE PROTEINS; RETINITIS PIGMENTOSA; VIRUSES;

ANIMALIA;

EID: 79959619541     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4419-1399-9_70     Document Type: Conference Paper

References (47)

1. Acland GM, Aguirre GD, Bennett J et al (2005) Long-term restoration of rod and cone vision by single dose rAAV-mediated gene transfer to the retina in a canine model of childhood blindness. Mol Ther 12:1072-1082 (Pubitemid 41723041)
2. Acland GM, Aguirre GD, Ray J et al (2001) Gene therapy restores vision in a canine model of childhood blindness. Nat Genet 28:92-95 (Pubitemid 32405824)
3. Ali RR, Sarra GM, Stephens C et al (2000) Restoration of photoreceptor ultrastructure and function in retinal degeneration slow mice by gene therapy. Nat Genet 25:306-310 (Pubitemid 30437318)
4. Allen D, Kenna PF, Palfi A et al (2007) Development of strategies for conditional RNA interference. J Gene Med 9:287-298 (Pubitemid 46746319)
5. Allocca M, DoriaM, PetrilloMet al (2008) Serotype-dependent packaging of large genes in adenoassociated viral vectors results in effective gene delivery in mice. J Clin Invest 118:1955-1964 (Pubitemid 351632397)
6. Andrieu-Soler C, Bejjani RA, de Bizemont T et al (2006) Ocular gene therapy: A review of nonviral strategies. Mol Vis 12:1334-1347 (Pubitemid 44725596)
7. Bainbridge JW, Smith AJ, Barker SS et al (2008) Effect of gene therapy on visual function in Leber's congenital amaurosis. N Engl J Med 358:2231-2239 (Pubitemid 351724452)
8. Bok D, Yasumura D, Matthes MT et al (2002) Effects of adeno-associated virus-vectored ciliary neurotrophic factor on retinal structure and function in mice with a P216L rds/peripherin mutation. Exp Eye Res 74:719-735 (Pubitemid 34948372)
9. Boon CJ, den Hollander AI, Hoyng CB et al (2008) The spectrum of retinal dystrophies caused by mutations in the peripherin/RDS gene. Prog Retin Eye Res 27:213-235
10. Buch PK, MacLaren RE, Duran Y et al (2006) In contrast to AAV-mediated Cntf expression, AAV-mediated Gdnf expression enhances gene replacement therapy in rodent models of retinal degeneration. Mol Ther 14:700-709 (Pubitemid 44480755)
11. Campochiaro PA, Nguyen QD, Shah SM et al (2006) Adenoviral vector-delivered pigment epithelium-derived factor for neovascular age-related macular degeneration: Results of a phase I clinical trial. Hum Gene Ther 17:167-176 (Pubitemid 43262032)
12. Cayouette M, Behn D, Sendtner M et al (1998) Intraocular gene transfer of ciliary neurotrophic factor prevents death and increases responsiveness of rod photoreceptors in the retinal degeneration slow mouse. J Neurosci 18:9282-9293 (Pubitemid 28512459)
13. Cepko CL, Austin CP, Yang X et al (1996) Cell fate determination in the vertebrate retina. Proc Natl Acad Sci U S A 93:589-595 (Pubitemid 26041133)
14. Cheng T, Peachey NS, Li S et al (1997) The effect of peripherin/rds haploinsufficiency on rod and cone photoreceptors. J Neurosci 17:8118-8128 (Pubitemid 27461036)
15. Cideciyan AV, Aleman TS, Boye SL et al (2008) Human gene therapy for RPE65 isomerase deficiency activates the retinoid cycle of vision but with slow rod kinetics. Proc Natl Acad Sci U S A 105:15112-15117
16. Conley S, Nour M, Fliesler SJ et al (2007) Late-onset cone photoreceptor degeneration induced by R172W mutation in Rds and partial rescue by gene supplementation. Invest Ophthalmol Vis Sci 48:5397-5407 (Pubitemid 351260838)
17. Connell G, Bascom R, Molday L et al (1991) Photoreceptor peripherin is the normal product of the gene responsible for retinal degeneration in the rds mouse. Proc Natl Acad Sci U S A 88:723-726 (Pubitemid 21916095)
18. Danos O (2008) AAV vectors for RNA-based modulation of gene expression. Gene Ther 15: 864-869 (Pubitemid 351712620)
19. Ding XQ, Nour M, Ritter LM et al (2004) The R172W mutation in peripherin/rds causes a cone-rod dystrophy in transgenic mice. Hum Mol Genet 13:2075-2087 (Pubitemid 39377830)
20. Farjo R, Naash MI (2006) The role of Rds in outer segment morphogenesis and human retinal disease. Ophthalmic Genet 27:117-122 (Pubitemid 44915774)
21. Farjo R, Skaggs JS, Nagel BA et al (2006b) Retention of function without normal disc morphogenesis occurs in cone but not rod photoreceptors. J Cell Biol 173:59-68
22. Farjo R, Skaggs J, Quiambao AB et al (2006a) Efficient non-viral ocular gene transfer with compacted DNA nanoparticles. PLoS ONE 1:e38
23. Farrar GJ, Kenna PF, Humphries P (2002) On the genetics of retinitis pigmentosa and on mutationindependent approaches to therapeutic intervention. EMBO J 21:857-864 (Pubitemid 34206159)
24. Farrar GJ, Kenna P, Jordan SA et al (1991) A three-base-pair deletion in the peripherin-RDS gene in one form of retinitis pigmentosa. Nature 354:478-480 (Pubitemid 21896863)
25. Gorbatyuk M, Justilien V, Liu J et al (2007a) Preservation of photoreceptor morphology and function in P23H rats using an allele independent ribozyme. Exp Eye Res 84:44-52 (Pubitemid 44792051)
26. Gorbatyuk M, Justilien V, Liu J et al (2007b) Suppression of mouse rhodopsin expression in vivo by AAV mediated siRNA delivery. Vis Res 47:1202-1208 (Pubitemid 46482623)
27. Hauswirth WW, LaVail MM, Flannery JG et al (2000) Ribozyme gene therapy for autosomal dominant retinal disease. Clin Chem Lab Med 38:147-153 (Pubitemid 30245783)
28. Hauswirth WW, Lewin AS (2000) Ribozyme uses in retinal gene therapy. Prog Retin Eye Res 19:689-710 (Pubitemid 30616360)
29. Kajiwara K, Hahn LB, Mukai S et al (1991) Mutations in the human retinal degeneration slow gene in autosomal dominant retinitis pigmentosa. Nature 354:480-483 (Pubitemid 21896864)
30. Kedzierski W, Lloyd M, Birch DG et al (1997) Generation and analysis of transgenic mice expressing P216L-substituted rds/peripherin in rod photoreceptors. Invest Ophthalmol Vis Sci 38:498-509 (Pubitemid 27085707)
31. Konstan MW, Davis PB, Wagener JS et al (2004) Compacted DNA nanoparticles administered to the nasal mucosa of cystic fibrosis subjects are safe and demonstrate partial to complete cystic fibrosis transmembrane regulator reconstitution. Hum Gene Ther 15:1255-1269 (Pubitemid 40052437)
32. LaVail MM, Yasumura D, MatthesMT et al (1998) Protection of mouse photoreceptors by survival factors in retinal degenerations. Invest Ophthalmol Vis Sci 39:592-602 (Pubitemid 28110693)
33. LaVail MM, Yasumura D, Matthes MT et al (2000) Ribozyme rescue of photoreceptor cells in P23H transgenic rats: Long-term survival and late-stage therapy. Proc Natl Acad Sci U S A 97:11488-11493
34. Liang FQ, Aleman TS, Dejneka NS et al (2001) Long-term protection of retinal structure but not function using RAAV.CNTF in animal models of retinitis pigmentosa. Mol Ther 4:461-472 (Pubitemid 33100284)
35. Maguire AM, Simonelli F, Pierce EA et al (2008) Safety and efficacy of gene transfer for Leber's congenital amaurosis. N Engl J Med 358:2240-2248 (Pubitemid 351724453)
36. Molday RS, Hicks D, Molday L (1987) Peripherin. A rim-specific membrane protein of rod outer segment discs. Invest Ophthalmol Vis Sci 28:50-61 (Pubitemid 17230190)
37. Mueller C, Flotte TR (2008) Clinical gene therapy using recombinant adeno-associated virus vectors. Gene Ther 15:858-863 (Pubitemid 351712619)
38. Nour M, Ding XQ, Stricker H et al (2004) Modulating expression of peripherin/rds in transgenic mice: Critical levels and the effect of overexpression. Invest Ophthalmol Vis Sci 45:2514-2521 (Pubitemid 38998844)
39. Nour M, Fliesler SJ, Naash MI (2008) Genetic supplementation of RDS alleviates a loss-offunction phenotype in C214S model of retinitis pigmentosa. Adv Exp Med Biol 613:129-138
40. Nystuen AM, Sachs AJ, Yuan Y et al (2008) A novel mutation in Prph2, a gene regulated by Nr2e3, causes retinal degeneration and outer-segment defects similar to Nr2e3 (rd7/rd7) retinas. Mamm Genome 9:623-633
41. O'Reilly M, Palfi A, Chadderton N et al (2007) RNA interference-mediated suppression and replacement of human rhodopsin in vivo. Am J Hum Genet 81:127-135 (Pubitemid 47001162)
42. Rhee KD, Ruiz A, Duncan JL et al (2007) Molecular and cellular alterations induced by sustained expression of ciliary neurotrophic factor in a mouse model of retinitis pigmentosa. Invest Ophthalmol Vis Sci 48:1389-1400 (Pubitemid 351261439)
43. Sarra GM, Stephens C, de Alwis M et al (2001) Gene replacement therapy in the retinal degeneration slow (rds) mouse: The effect on retinal degeneration following partial transduction of the retina. Hum Mol Genet 10:2353-2361 (Pubitemid 33069541)
44. Schlichtenbrede FC, MacNeil A, Bainbridge JW et al (2003) Intraocular gene delivery of ciliary neurotrophic factor results in significant loss of retinal function in normal mice and in the Prph2Rd2/Rd2 model of retinal degeneration. Gene Ther 10:523-527 (Pubitemid 36395269)
45. Schlichtenbrede FC, da Cruz L, Stephens C et al (2003) Long-term evaluation of retinal function in Prph2Rd2/Rd2 mice following AAV-mediated gene replacement therapy. J Gene Med 5: 757-764 (Pubitemid 40309713)
46. Stricker HM, Ding XQ, Quiambao A et al (2005) The Cys214→Ser mutation in peripherin/rds causes a loss-of-function phenotype in transgenic mice. Biochem J 388:605-613 (Pubitemid 40839938)
47. van Nie R, Ivanyi D, Demant P (1978) A new H-2-linked mutation, rds, causing retinal degeneration in the mouse. Tissue Antigens 12:106-108 (Pubitemid 9002921)